- Report
- June 2026
- 222 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- June 2026
- 205 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- June 2026
- 278 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- June 2026
- 138 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- June 2026
- 465 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- June 2026
- 189 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- June 2026
- 428 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- June 2026
- 221 Pages
Global
From €5262EUR$5,800USD£4,535GBP
- Report
- July 2026
- 263 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 281 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 330 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 212 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 183 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 220 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 267 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 279 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 371 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 220 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 260 Pages
Global
From €5307EUR$5,850USD£4,574GBP
- Report
- July 2026
- 279 Pages
Global
From €5307EUR$5,850USD£4,574GBP

The Genetic Disease market is a subset of the Genomics market that focuses on the diagnosis, treatment, and prevention of genetic diseases. It is a rapidly growing field, driven by advances in technology and the increasing availability of genetic testing. Companies in this market are developing new treatments and therapies for genetic diseases, as well as diagnostic tests and tools to identify and monitor them. They are also researching ways to prevent genetic diseases from occurring in the first place.
Companies in the Genetic Disease market include Illumina, Thermo Fisher Scientific, BGI, Genomic Health, and Invitae. These companies are developing innovative products and services to help diagnose, treat, and prevent genetic diseases. They are also investing in research and development to further advance the field. Show Less Read more